Dr. Richard Larivière is a professor in the Department of Medicine at Laval University, and a researcher within the Endocrinology and Nephrology axis of the CHU of Quebec Research Centre. He is also Director of Master’s and PhD programs in Clinical and Biomedical Sciences of the Faculty of Medicine at Laval University. Following his doctoral studies in Clinical Sciences (cardiovascular pharmacology) at the Université de Montréal, and postdoctoral studies in molecular endocrinology at McGill University, Dr. Larivière established himself as a professor-researcher in nephrology and hypertension at L’Hôtel-Dieu de Québec. He is an active member of the Amgen-Laval University Research Chair in Nephrology, a multidisciplinary group of fundamentalist and clinical researchers.

The main objective of Dr. Larivière’s research is to better define the mechanisms of arterial hypertension and remodeling of the blood vessel wall. More specifically, he studies the role of endothelial dysfunction, that is, factors derived from the vascular endothelium in the pathogenesis of arterial hypertension, vascular and renal damage in the case of chronic renal failure, and aging. Over the years, he has demonstrated that an imbalance in endothelial production of vasoconstrictor and vasodilator factors, as well as pro-inflammatory factors, contributes significantly to the increase of arterial pressure and rigidity by stimulating, among other things, hypertrophic remodeling and calcification of the blood vessel wall. He has also demonstrated that endothelial dysfunction can be modulated by various endocrine factors and pharmacological agents, including certain drugs. Dr. Larivière’s research uses a variety of experimental models and human tissue libraries.

L'Hôtel-Dieu de Québec
10, rue McMahon
2853
Québec, Québec
Canada G1R 2J6
+1 418-525-4444, extension 15587
Richard.Lariviere@crchude...

Latest news

Data not available

35 entries « ‹ 3 of 4 › »

Rancourt ME, Rodrigue ME, Agharazii M, Lariviere R, Lebel M

Role of oxidative stress in erythropoietin-induced hypertension in uremic rats

Journal Article

Am J Hypertens, 23 (3), 2010.

Abstract | Links:

Therrien F, Lemieux P, Belanger S, Agharazii M, Lebel M, Lariviere R

Protective effects of angiotensin AT1 receptor blockade in malignant hypertension in the rat

Journal Article

Eur J Pharmacol, 607 (1-3), 2009.

Abstract | Links:

Bourgoin F, Bachelard H, Badeau M, Melancon S, Pitre M, Lariviere R, Nadeau A

Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet

Journal Article

Am J Physiol Heart Circ Physiol, 295 (3), 2008.

Abstract | Links:

Rodrigue ME, Brochu I, D' orleans-Juste P, Larivière R, Larivièrea R, Lebel M

Effect of erythropoietin on blood pressure and on the vascular endothelial ET-1/ETB receptor system

Journal Article

Am J Hypertens, 21 (6), 2008.

Abstract | Links:

Mélançon S, Bachelard H, Badeau M, Bourgoin F, Pitre M, Larivière R, Nadeau A

Effects of high-sucrose feeding on insulin resistance and hemodynamic responses to insulin in spontaneously hypertensive rats

Journal Article

Am J Physiol Heart Circ Physiol, 290 (6), 2006.

Abstract | Links:

Dao HH, Bouvet C, Moreau S, Beaucage P, Lariviere R, Servant MJ, de Champlain J, Moreau P

Endothelin is a dose-dependent trophic factor and a mitogen in small arteries in vivo

Journal Article

Cardiovasc Res, 71 (1), 2006.

Abstract | Links:

Lebel M, Rodrigue ME, Agharazii M, Lariviere R

Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin

Journal Article

Am J Hypertens, 19 (12), 2006.

Abstract | Links:

Lavoie P, Robitaille G, Agharazii M, Ledbetter S, Lebel M, Lariviere R

Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats

Journal Article

J Hypertens, 23 (10), 2005.

Abstract | Links:

Rodrigue ME, Lacasse-M S, Lariviere R, Lebel M

Cyclooxygenase inhibition with acetylsalicylic acid unmasks a role for prostacyclin in erythropoietin-induced hypertension in uremic rats

Journal Article

Can J Physiol Pharmacol, 83 (6), 2005.

Abstract | Links:

Lariviere R, Moreau C, Rodrigue ME, Lebel M

Thromboxane blockade reduces blood pressure and progression of renal failure independent of endothelin-1 in uremic rats

Journal Article

Prostaglandins Leukot Essent Fatty Acids, 71 (2), 2004.

Abstract | Links:

35 entries « ‹ 3 of 4 › »
Signaler des ajouts ou des modifications

Active projects

  • Hydrochlorothiazide and accelerated CKD-related vascular calcification, from 2023-07-01 to 2025-06-30
  • Rôle de la dysfonction endothéliale dans le remodelage et la calcification vasculaire en insuffisance rénale chronique, from 2016-04-01 to 2025-03-31

Recently finished projects

  • Accelerated CKD-related vascular calcification: Role of thiazide-type, thiazide-like and loop diuretics, from 2020-10-01 to 2023-05-31
  • Proline hydroxylase inhibitors: linking HIF-1 to arterial calcification, from 2019-07-01 to 2021-09-30
Data provided by the Université Laval research projects registery